Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

RLS Global AB (publ) Interim Report, Q1, 2023

RLS Global
Download udgivelse
JANUARY 1st - MARCH 31st (Previous year in brackets)
  • Net sales amounted to TSEK 89 (TSEK 305)
  • Earnings before interest and taxes (EBIT) amounted to MSEK -7,5 (MSEK -5,3)
  • Earnings per share after dilution at SEK -0,09 (SEK 0,07)
  • Cash flow from operating activities amounted to TSEK -7 084 (TSEK -6 730)
  • Liquid assets at the end of the period MSEK 13,4 (MSEK 4,7)
  • Equity ratio was 82 % (77 %)
Summary of events during FIRST quarter
  • An extra AGM was held 9 February.
  • Lars Johansson was elected Board Member and Chairman of the Board at the extra AGM.
  • Wounds UK publishes the peer-reviewed article "The in vitro antibiofilm performance of ChloraSolv® Wound Debridement Gel". The article concludes that ChloraSolv wound debridement gel shows notably greater antibiofilm activity, in vitro, compared to other debridement products and techniques.
Summary of events after FIRST quarteR
  • The UK MHRA (Medicines & Healthcare products Regulatory Agency) has approved RLS' application to extend the current clinical study for pressure ulcers to UK.
  • Eva Jagenheim leaves her role as CFO in RLS Global AB. She will remain in service during her notice period, at latest to October, to ensure a smooth transition to her successor.

The Interim Report Q1, 2023, is enclosed and is also available at https://rls.global/financial-information/financial-reports-eng/

Publication
This information was submitted for publication through the agency of the below contact person, at 08.30 CET on May 31st 2023.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team